Table V:
Significant exacerbation Predictors | All Blacks (n=450)a | All non-Hispanic Whites (n=1108)a | ||
---|---|---|---|---|
RR (95% CI) | P-value | RR (95% CI) | P-value | |
Exacerbation history | 0.053 | <0.001 | ||
≥2 vs 0 | 2.1 (1.10–3.84) | 0.024 | 2.5 (1.45–4.18) | <0.001 |
1 vs 0 | 1.7 (0.92–3.03) | 0.091 | 1.8 (1.20–2.84) | 0.005 |
Sex (Females versus Males) | 1.1 (0.63–1.83) | 0.79 | 0.7 (0.47–1.01) | 0.054 |
% predicted FEV1, per 14% increase | 0.7 (0.54–0.95) | 0.022 | 0.8 (0.62–0.93) | 0.008 |
Relative rates (RR) for continuous variables expressed per change by one standard deviation. Models include median percentage African genetic ancestry (AA) which varied between race dues to marked differences in distribution of Native American, European, and African ancestries. Models also include protocol, age, sex, FEV1, race, and exacerbation history.
Poisson regression, repeated measures.